Associate Director, Analytical Development

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you’re ready to join us at the edge of something unstoppable, let’s make a profound impact together for our patients, for your career, for what’s beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Associate Director, Analytical Development As the Associate Director of Analytical Development reporting to the Senior Director of Analytical Chemistry you will be responsible for driving progress of both early and late-stage molecules by delivering phase - appropriate analytical methods, validation and tech transfers. You will partner with cross-functionally supporting process development, formulations, CMC, and quality activities. In addition, you will bring demonstrated team playing and collaboration skills and experience operating effectively in a fast-paced, growth-stage biotech environment. This role can be based out of our San Francisco, CA or Boston, MA office and will require 10-15% travel . Your work will primarily encompass: Supporting analytical method development, qualification, and validation for starting materials, in-process control, process intermediates, drug substances and drug products Conducting analytical technical review of method validation/qualification protocols, data and reports generated at CDMOs for drug substances and drug products Reviewing and approving analytical reports or certificates of analyses from CDMOs for batch release and stability testing of drug substances and drug products Working on stability programs, monitoring/trending stability data and establishing retest periods or shelf lives for drug substances or drug products Providing technical input and resolving analytical and quality control issues, deviations, OOS and OOT investigations Supporting regulatory filings (IND, IMPD, NDA, MAA) submissions as needed Representing analytical Chemistry at internal and external scientific team meetings as needed Staying current with state-of-the art approaches and applicable global regulations and industry standards Ideal Candidate Profile >>> A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge , experience , and attributes for this role. Knowledge Bachelors, required; MS or PhD in Chemistry or equivalent scientific discipline strongly preferred Expertise in analytical development and quality control for both drug substances (emphasis) and drug product Knowledge of cGMP, ICH, and FDA regulations/guidance Experience Minimum of 7+ years of relevant industry experience in small molecule drug substance and drug product analytical development and quality control, including late-stage clinical development and preparation for product registration Experience working in an environment that strives to ensure internal technical expertise in-house while driving CDMO capabilities to meet milestones for multiple projects Experience in partnering with cross functional teams providing analytical development leadership across programs and projects Effective written, oral communication and interpersonal skills Attributes An